Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University...
-
Upload
hilary-watson -
Category
Documents
-
view
215 -
download
0
Transcript of Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University...
![Page 1: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/1.jpg)
Molecular Adsorbent Recirculating System
Patrick Brophy MD
Director Pediatric Nephrology, University of Iowa Children’s
Hospital
![Page 2: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/2.jpg)
Outline
• Hepatic Dialysis- Liver Support
• MARS™
• Rationale
• Indications
• Outcomes
• Future Directions
![Page 3: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/3.jpg)
Hepatic Failure
• Definition: Loss of functional liver cell mass below a critical level results in liver failure (acute or complicating a chronic liver disease)
• Results in: hepatic encephalopathy & coma, jaundice, cholestasis, ascites, bleeding, renal injury, death
![Page 4: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/4.jpg)
Hepatic Failure• Production of Endogenous Toxins & Drug Metabolic
Failure
• Bile Acids, Bilirubin, Prostacyclins, NO, Toxic fatty acids, Thiols, Indol-phenol metabolites
• These toxins cause further necrosis/apoptosis and a vicious cycle
• Detrimental to renal, brain and bone marrow function; results in poor vascular tone
![Page 5: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/5.jpg)
History
Stadlbauer and Jalan. Acute Liver Failure: liver support TherapiesCurrent Opin in Crit Care. 2007; 13:215-21
![Page 6: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/6.jpg)
MARS™MARS™ Flux Filter
ADSORPTION COLUMNS
DIALYSISDiaFlux Filter
Patient BloodCircuit
20-25% AlbuminCircuit
DialysisCircuit
![Page 7: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/7.jpg)
MARS Flux Filter
Kapoor D., Journal of Gastroenterology and Hepatology, 2002
![Page 8: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/8.jpg)
![Page 9: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/9.jpg)
pCRRT Rome 2010
Technical Aspects• Filters :
– MARS™ flux : 2m2 ECV = 150 ml + lines, 600ml 20% Alb– MARSMini™: 0.6m2 ECV = 56ml + lines, 500ml 20% Alb *** (not
Available in US)– PRISMARS™– 1 kit = $ 2700 (USD)
• Flow Rates :– Blood flow rate: 4-10 ml/kg/min– Albumin dialysate Flow Rate = BFR– UFR : 2000ml/h/1.73m2 in CVVH or in CVVHDF mode
• Anticoagulation:– No anticoagulation – Heparin (5 U/kg/h)– Citrate
![Page 10: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/10.jpg)
Albumin Bound Toxins Removed During MARS Therapy
• Aromatic Amino Acids• Bilirubin• Bile Acids• Copper• Middle and Short Chain
Fatty Acids• Nitric Oxide (S-
Nitrosothiol)• Protoporphyrin
Water Soluble Substances Removed During MARS Therapy
• Ammonia• Creatinine• Tryptophan• Tumor Necrosis Factor
Alpha• Urea• IL-6
![Page 11: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/11.jpg)
Substances Not Removed During MARS™
• Clotting Factors (Factor VII 50,000 Daltons)– Improvement in Factor VII levels after
repeated treatments in small studies
• Immunoglobulin G (150,000 Daltons)
• Hormone binding proteins
• Albumin
![Page 12: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/12.jpg)
12
Rationale
• To provide an environment facilitating recovery- isolated or as a component of MOSF Therapy
• To prolong the window of opportunity for LTx : Bridge to Transplantation
• To allow waiting for the native liver recovery: Bridge to recovery
![Page 13: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/13.jpg)
Indications
• Intoxications (US ***)
• Acute Liver Failure (ALF)– Hepatorenal Syndrome
• Acute on Chronic Liver Failure (AoCLF)
• Hepatic Encephalopathy
• Refractory Pruritus in Liver Failure
• Sepsis / SIRS / MODS
![Page 14: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/14.jpg)
Intoxications leading to Acute Liver Failure
• Exogenous:– Acetaminophen– Amanita Toxin
• Endogenous: – Inborn Error Metabolism– Wilson disease, neonatal hemochromatosis
• Removal of inflammatory Toxins– Sepsis/SIRS– MOSFSee appendix for references
Multiple studies have shown MARS to be an effective therapy in these types of toxin induced ALF
![Page 15: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/15.jpg)
Acute Liver Failure
0
0,2
0,4
0,6
0,8
1
0 5 10 15 20 25 30
treatment days
cum
ula
tive
su
rviv
al
MARS(n=8) HDF(n=5)
p = 0,0123
![Page 16: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/16.jpg)
![Page 17: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/17.jpg)
Acute Liver Failure
Data -2000-2009 PICU at Pédiatriques Hôpital Femme Mère Enfant, Lyon, France: Dr. E Javouhey- presented ppCRRT meeting 2010
Weight Kg
Age month
Liver disease
Underlying disase
Indication Transplantation Outcome
1 9 10 Biliary atresia Graft dysfunction
ALF Living donor Severe disabilities
2 7 7 Fulminant hepatitis
Cystic fibrosis
ALF Cadaveric Donor Died
3 9,5 28 Biliary cirrhosis End stage renal failure
AoCLF Liver-Kidney Alive
4 13 36 Byler disease Chronic graft rejection
RP Living donor Alive
5 6,3 9 Biliary atresia Biliary Cirrhosis
AoCLF/RP Cadaveric Donor Alive
6 50 166 Wilson disease ALF Living donor Alive 7 55 180 Biliary atresia Chronic graft
rejection RP Living donor Alive
8 37 189 Fulminant hepatitis
Graft Dysfunction
RP Living donor Alive
9 6,8 6 Fulminant hepatitis
ALF Living donor Alive
10 20 139 Wilson disease ALF Cadaveric Donor Alive 11 30 135 Wilson disease ALF Cadaveric Donor Alive 12 50 181 Wilson disease
Priamary graft dysfunction
ALF
Cadaveric donor X2
Alive
![Page 18: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/18.jpg)
![Page 19: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/19.jpg)
![Page 20: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/20.jpg)
Acute on Chronic Liver Failure
• Increased Survival– 24 adult patients with AoCLF
• 92% 30 day survival in MARS group• 50% 30 day survival in control group
– Heemann U., Hepatology 36: 949-958, 2002
![Page 21: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/21.jpg)
![Page 22: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/22.jpg)
Benefits of MARS
• Improvement in Hemodynamic Stability– Increased systemic vascular resistance– Increased mean arterial pressure– Decreased portal venous pressure in AoCLF– Improvement in renal blood flow (RBF)
– Laleman W., Critical Care 10:R108, 2006– Schmidt LE., Liver Transpl 9: 290-297, 2003– Kapoor D., Journal of Gastroenterology and Hepatology
2002, 17: S280 – 86, 2002– Mitzner SR., J Am Soc Nephrol 12: S75-82, 2006
![Page 23: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/23.jpg)
Hepatic Encephalopathy
Endogenous Benzodiazepine
LIVER FAILURE MARS
Ammonia
Nitric Oxide
Fischer Index
Glutamine Glutamate
Loss of CerebralAuto-regulation
IntracranialHypertension
CerebralEdema
CerebralIschemia
Herniation
![Page 24: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/24.jpg)
Benefits of MARS• Improvement in Hepatic Encephalopathy
Hassanein T., Hepatology 46: 1853-1862, 2007
![Page 25: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/25.jpg)
Tolerance and efficacy Tolerance Efficacy Weight
kg Age
month Indication Hemodynamic Transfusion Neurological Pruritus Humor
9 10 ALF Moderate Yes (+/-)
7 7 ALF Bad No NA
ALF
6,8 6 ALF Bad Yes NA
9,5 28 AoCLF Good No Yes Yes Yes 13 36 RP Good No Yes Yes Yes
6,3 9 AoCLF/RP Good Yes Stable Stable NA 55 180 RP Good No Yes Yes Yes
AoCLF/RP
37 189 RP Good No Yes Yes Yes
50 166 ALF Good Yes Stable Wilson disease 20 139 ALF Good Yes NA
30 135 ALF Good Yes Sable, no EH 50 181 ALF
Graft dysfunction
Good Atrial
tachycardia
yes Yes
Data -2000-2009 PICU at Pédiatriques Hôpital Femme Mère Enfant, Lyon, France: Dr. E Javouhey- presented ppCRRT meeting 2010
![Page 26: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/26.jpg)
Risks• Hemodynamic
Instability– Has been seen
primarily in children weighing < 10kg also undergoing hemodialysis
– Overall improvement with continued therapy
• Thrombocytopenia• Bleeding
Complications• Transfusion of Blood
Products
![Page 27: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/27.jpg)
Cost Benefit
![Page 28: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/28.jpg)
Non-Biological artificial support
• Issues:– Still don’t understand the complexity of the liver
and the causes of hepatic encephalopathy/coma– May be removing both good (growth factors-for
liver regeneration) and bad substances– Need to standardize end points in these studies– Multicenter RCTs are desperately required in
Pediatrics
![Page 29: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/29.jpg)
Future HorizonsHuge potential Impact on critical care & Transplantation
Potential for managing patients chronically as an outpatient with intractable pruritus- High impact on quality of life:Leckie et.al. Outpatient albumin dialysis for Cholestatic patients with intractable pruritus Aliment Pharmacol Ther 2012; 35: 696-714
Schaefer et.al. MARS dialysis in children with cholestatic pruritus. Pediatr Nephrol 2012; 27: 829-34
![Page 30: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/30.jpg)
Thank You
• Pediatric Dialysis Staff
• Mary Lee Neuberger
• Critical Care physicians/Nursing
• Pharmacy
![Page 31: Molecular Adsorbent Recirculating System Patrick Brophy MD Director Pediatric Nephrology, University of Iowa Children’s Hospital.](https://reader036.fdocuments.in/reader036/viewer/2022062423/56649eb15503460f94bb77bc/html5/thumbnails/31.jpg)
Appendix